Foot-and-mouth disease virus (a member of the picornavirus group) RNA could be translated effectively in an S-3o extract from Ehrlich ascites tumour cells. This translation was inhibited by aurintricarboxylic acid, cycloheximide, puromycin and RNase. Cell-free products of translation were identified by disc gel electrophoresis and immunoprecipitation with specific antisera. Gel electrophoresis of the products without prior immunoprecipitation suggested the synthesis of some of the non-capsid proteins and capsid proteins VP1, VP2 and VP3 of the virus. Immunoprecipitations with antisera against whole virus and VP3 indicated the synthesis of VP3 and of at least two additional peptides of IOOOOO and 56ooo daltons containing antigenic sites of VP3. Gel electrophoresis after immunoprecipitation with antiserum against virus infection-associated antigen indicated the synthesis of a different 56ooo-dalton protein appearing to resemble non-capsid protein NCVP 5. The amount of foot-and-mouth disease virus and VP3-specific peptides in the virus RNA-directed products were measured by immunoprecipitation.
INTRODUCTION
Synthesis of proteins in cell-free systems programmed with animal virus RNA can provide significant information about the nature of the genome RNA, processing of virus proteins, immunogenic properties of virion polypeptides and the role of different species of RNA found in virus-infected cells.
RNAs from a number of picornaviruses (e.g. polio, encephalomyocarditis [EMC] , mouse Elberfeld and Mengo) have been translated in cell-free systems. Poliovirus RNA has been translated in cell-free systems from E~cherichia coli into polypeptides immunologically related to poliovirus capsid proteins (Warner, Madden & Darnell, 1963) or to heterogeneous polypeptides similar to those synthesized in vivo (Rekosh, Lodish & Baltimore, I97O) . In some studies, EMC virus RNA has been translated into capsid proteins in cell-free systems from Krebs ascites cells (Kerr et al. 1962; Mathews & Korner, I97O; Smith, Marcker & Mathews, I97O; Aviv, Boime & Leder, 1971; Dobos, Kerr & Martin, 197I) . Eggen & Shatkin (i972) and Oberg & Shatkin (I972) compared the translation of RNAs from EMC virus, mouse Elberfeld virus and Mengovirus in cell-free systems from animal cells. They reported that: (I) in vitro translation of picornavirus RNA starts at a single initiation site;
(2) the gel profiles of in vitro products from these three viruses are almost indistinguishable; and (3) a correlation exists in the gel electrophoretic patterns between the mouse Elberfeld virus RNA-directed cell-free products and authentic precursor and coat proteins.
Foot-and-mouth disease virus (FMDV) is a picornavirus containing a single-stranded 37S RNA (Strohmaier & Mussgay, I959; Brown & Cartwright, I964; Arlinghaus, Polatnick & Vande Woude, I966 ) that acts as a polycistronic mRNA in the virus-infected cells (Vande Woude & Ascione, i974; Black, I975) . The RNA in the infected cell is translated into a large polypeptide product that is subsequently cleaved into smaller non-capsid and capsid virus proteins. Previous cell-free translation of FMDV RNA (Ascione & Vande Woude, 1971 ) required ribosome-associated initiation factors from virus-infected cells and primarily produced products of high mol. wt. The present report describes a cell-free protein synthesizing system from Ehrlich ascites tumour cells which translates FMDV RNA efficiently, without added initiation factors, into a number of non-capsid precursor proteins and capsid proteins identified by gel electrophoresis and immunoprecipitation.
METHODS
Growth of FMDV, labelling of virus proteins and extraction of virus RNA. FMDV (type A12 , strain 1 I9) was grown in 2-1itre Baxter bottle cultures of baby hamster kidney (BHK) cell line passage 2T, clone 13 (Polatnick & Bachrach, I964) , concentrated by precipitation with 6 ~ polyethylene glycol (Wagner, Card & Cowan, I97o ) and purified by CsC1 density gradient ceatrifugation (Bachrach, Trautman & Breese, I964) .
Radioactive virus was prepared by growing viru s in the presence of 5/zg/ml of actinomycin D and labelling with 2o to 37 #Ci/ml of 35S-methionine 0oo to 2o0 Ci/mmol). For labelling virus-induced cytoplasmic proteins, BHK cells were infected with 2o to 3o p.f.u./cell, incubated for 3"5 h in the presence of 5 #g/ml of actinomycin D, removed from the glass, adjusted to about Io ~ cells/ml in the growth medium and labelled with zo #Ci/ml of 35S-methionine for I h at 37 °C. Mock-infected cells were similarly labelled to serve as controls. After the cells were labelled, they were pelleted by centrifugation, washed thoroughly in the growth medium and disrupted in a Dounce homogenizer in a buffer containing Io mM-NaC1, Io mM-tris-HC1 (pH 7"5) and o'5 ~ Nonidet-P4o. Nuclei were removed, and the supernatant fluid was dialysed against 6o mM-tris-HC1 (pH 7"I), I ~ SDS and 5 ~ fl-mercaptoethanol (ME). This preparation was used in polyacrylamide gel electrophoresis (PAGE) in combination with in vitro synthesized proteins where indicated.
For isolation of virus RNA, purified virus was dialysed overnight at 4 °C against 5o mMpotassium phosphate (pH 7"5) and 2oo mM-KC1 and pelleted by centrifugation at 65ooo rev[ min for 2 h. The virus pellet was suspended in 7o mM-sodium acetate (pH 5"o) containing o'5 ~ SDS, and RNA was extracted by the phenol and chloroform procedure of Penman (I969). The RNA was precipitated twice with 15o mM-potassium acetate and 3 vol. of ethanol at -20 °C, dissolved in water, clarified by centrifugation (5ooo rev/min for I5 min) and stored in liquid nitrogen.
Preparation of Ehrlich ascites cell-free protein synthesizing system and in vitro protein synthesis. Preparation of a cell-free system (S-3o) from ascites cells grown in mice and in vitro protein synthesis have been described (Chatterjee & Weissbach, I974) . In the experiments reported here, unless otherwise mentioned, the incubation mixture for in vitro protein synthesis had a final volume of 60/d and contained 2o mM-tris-HC1 (pH 7"5), t Iz mM-KC1, 3"5 mM-magnesium acetate, 5 raM-ME, I"o4 mM-ATP, o'42 mM-GTP, 5 mM-creatine phosphate, o.2 mg/ml of creatine kinase, 25 #M each of 19 unlabelled amino acids, o. I8 mg/ml of rabbit liver tRNA, 5/tCi of 3H-leucine (50 Ci/mmol) or I5/~Ci 35S-methionine (Ioo Ci/mmol) and about 2"5 mg/ml of S-3o protein. After an incubation of 3o min at 37 °C, hot trichloroacetic acid (TCA)-precipitable radioactivity was measured (Chatterjee, Chuang & Weissbach, I974) .
Disc gel electrophoresis. For PAGE, polypeptide products were prepared in vitro in I2O to 24o #1 reaction mixtures incubated for I h. The incubation mixture was then made 50 mM in EDTA, 5o #g/ml in pancreatic RNase and incubated for an additional 2o rain at 37 °C. The polypeptide products were precipitated with to ~ TCA, washed twice with 5 ~ TCA, twice with acetone and dried. The dried products were suspended in PAGE o/ SDS, sample preparation buffer containing 60 mM-tris-HC1 (pH 7"I), Io ~ glycerol, 2/o 5 ~ ME, 8 M-urea and phenol red, mixed with appropriate marker proteins and heated at Ioo °C for 3 to 4 rain. Immunoprecipitates for PAGE were dissolved in sample preparation buffer, mixed with appropriate markers, heated and electrophoresed (Maizel, 197I) at constant voltage in I2"5 ~o polyacrylamide gels 0o cmx o.6 cm) containing 8 M-urea until the phenol red had migrated 9 cm. Gel sections (I or 2 mm thick) were sliced, digested with o'3 ml 5o ~ hydrogen peroxide at 60 °C overnight and counted for radioactivity. Where indicated, proteins in gel columns were stained with Coomassie brilliant blue and scanned at 6oo nm in a recording spectrophotometer.
Sera and antisera. Rabbit anti-guinea pig IgG serum was purchased from Grand Island Biological Co., Grand Island, New York. Pre-immune and antisera from guinea pigs against inactivated type A and C viruses, against capsid protein VP 3 from type A FMDV, and type C antiserum from convalescent cattle were kindly provided by P. D. McKercher and D. M. Moore of this Centre.
Immunoprecipitation. Indirect immunoprecipitations on the products from in vitro incubations were performed in the presence of an excess of antibody (Laskov & Scharff, I97o) . Samples of 20o to 4oo #1 of the incubated products were mixed with appropriate antisera at dilutions that gave approx. 7o ~ precipitating efficiency in homologous reactions and 7"5 ~ efficiency between FMDV and anti-VPa serum (Table 2, Expt. I and 2) and incubated at 37 °C for 3o min. Heterologous antiserum or IgG directed against the first IgG was added at equivalence, and the samples were further incubated for another 2 h at 37 °C. The immunoprecipitates were collected by centrifugation at 3ooo rev/min for Io rain, washed 2 to 3 times with 0"85 ~ NaC1 containing 20o raM-potassium phosphate (pH 7"5) and o.2 ~ Triton X-too and then used in gel electrophoresis and quantitative immunoprecipitation experiments. For quantitative immunoprecipitation, the immunoprecipitates were taken up in 5 ~ TCA to determine the hot TCA-precipitable radioactivity (Chatterjee et al. I974) .
RESULTS

Protein synthesis directed by FMD V RNA
RNA isolated from purified virus could be effectively translated by the S-3o extract from Ehrlich ascites tumour cells. Fig. I shows the effect of RNA on ~H-leucine incorporation in the absence and presence of a 0"5 M-KC1 wash from rabbit reticulocyte ribosomes. A sixfold to ninefold stimulation in leucine incorporation over the background (incorporation in the absence of RNA) was obtained at approx. 9 #g of RNA[6o #1 of incubation medium Jn the absence of the o'5 M-KC1 wash; whereas in the presence of the o'5 M-KC1 wash, used as a source of initiation factors, an additional stimulation of twofold to threefold could be obtained with certain preparations of S-3o extracts ( Fig. I and Table I ). Very high concentrations of RNA were inhibitory to leucine incorporation, and this inhibition could not be overcome by the o'5 M-KC1 wash. Fig. 2 shows that FMDV RNA-directed leucine incorporation increased almost linearly for 45 to 6o min at 37 °C. The optimum magnesium concentration for this incorporation was approx. 3"5 mg (data not shown). Table I shows the effects of inhibitors of protein synthesis on the incorporation of ~sS-methionine and ~H-leucine directed by FMDV RNA. Puromycin and cycloheximide, inhibitors of peptide chain elongation, and pancreatic RNase inhibited methionine and leucine incorporation by more than 9o %. Aurintricarboxylic acid (ATA), which in low concentration is a potent inhibitor of initiation of haemoglobin synthesis (Lodish, Housman & Jacobsen, ~97I) , reduced the incorporation of methionine below the background level, indicating that the drug inhibited the initiation step of FMDV RNA-directed protein synthesis. The slight incorporation of leucine over that of background is presumed to be due to chain elongation.
Effect of inhibitors on protein synthes&
Electrophoretic identification of proteins synthesized in vitro
The polypeptides synthesized in vitro in the absence and presence of FMDV RNA were compared by PAGE with those made in vivo in BHK cell cytoplasm in the absence (Fig.   3 a, b) and presence (Fig. 4) of FMDV infection. A comparison of radioactivity of gel slices of in vitro synthesized polypeptides (Fig. 3a, b and Fig. 4, solid lines) indicates that protein synthesized in the absence of FMDV RNA was mostly of small mol. wt., whereas that synthesized in the presence of FMDV RNA was heterogeneous and could be grouped into large, medium and small peptides around gel slices 5, 24 and 46, respectively. Similar comparison of in vivo made polypeptides ( Fig. 3 and 4 , broken lines) indicates that the protein made in the absence of virus infection formed a somewhat unresolved and continuous band from gel slices zo to 8o in Fig. 3 a, b , whereas protein made in the presence of virus infection (Fig. 4) was to a large extent discrete and could be grouped into large, medium and small peptides. Polyacrylamide gel co-eleetrophoresis of aH-leucine-labelled FMDV RNA-directed polypeptides ( ) with asS-methionine-labelled purified virus (---).
the products of cleavage of the original polyprotein, whereas capsid proteins are derived from NCVP precursors by secondary cleavage. Some of the polypeptides made in vivo are identified in Fig. 4 . On the basis of co-electrophoresis, the in vitro system appears to have yielded the cleavage products NCVP2, a, 5, g as well as VP1, VP2 and VP 3. In accord with these results, VPa, VP2 and VPa from asS-methionine-labelled purified virus were found to co-electrophorese with the corresponding virus RNA-directed in vitro all-labelled peptides (Fig. 5) Identification by immunoprecipitation of proteins synthesized in vitro To augment the electrophoretic observations, the polypeptides from in vitro syntheses were compared with regard to their ability to be immunoprecipitated by antisera against whole virus and capsid peptide VPa. Fig. 6 shows the gel electrophoretic patterns of the specific immunoprecipitates. Virus RNA-directed in vitro synthesized polypeptides contained VP 3 (Fig. 6a, b) which could be precipitated with either antiserum. Moreover, both antisera precipitated at least two additional peptides a and b which are larger than virion polypeptides VP1 4. The estimated mol. wt. of peptides a and b are Iooooo and 56ooo, respectively, and they appear to be the precursors of VPa containing its antigenic site(s). Although not shown, the proportions of radioactivity in a, b and VPa were variable in repeated experiments, indicating different degrees of processing of the precursors into VPa. None of these peptides could be precipitated by pre-immune guinea pig serum (Fig. 6c) .
After isolation, the outermost and trypsin-sensitive peptide of the virion has been reported to produce virus neutralizing antibody in swine (Bernard et aI. I974). Bachrach et al. 0975) have reported that this peptide (i.e. VPa in the present communication) will immunize swine and produce neutralizing and virus-precipitating antibodies, whereas specific antibodies to VP1 and VP2 did not precipitate virus. These findings indicate why antisera against whole virus or VPa precipitated only VPa and its presumed precursors.
Measurement of in vitro synthesized proteins
Quantitative immunoprecipitation analyses were carried out to determine the amounts of VPa and of precursors with VPa antigenic site(s) in the in vitro products (Table 2) . Antiserum against FMDV precipitated 72 ~oo of the input radioactivity of whole virus (Table 2, while that against VP3 precipitated 71 ~ of input VP 3 and only 7"5 ~ of input whole virus (Table 2, Expt. I and 2). Under the same experimental conditions, antisera against FMDV and VP3 precipitated 4 to 7 ~ and 2o to 26 ~, respectively, of the FMDV RNA-directed in vitro polypeptides (Table 2, Expt. 4 and 5). This constitutes a fourfold to sixfold increase over peptides synthesized in the absence of FMDV RNA (Table 2, Expt. 3)-Pre-immune serum was not effective in immunoprecipitation reactions (Table a, Expt. 4).
Experiments to identify the in vitro synthesized 56ooo tool. wt. protein(s)
During the early phase of FMDV infection in tissue cultures, guinea pigs and cattle, a "virus-infection-associated' (VIA) antigen is produced which is not type-specific and was not detected in I4oS virus particles (Cowan & Graves, I966 ) . More recently, it has been suggested from mol. wt. data, that VIA antigen is present in small amounts in virus particles (Sangar, Rowlands & Black, I975) . VIA antigen co-electrophoreses with NCVP 5 (Vande (Fig. 4) , the in vitro product was tested by immunoprecipitation with type C virus antiserum from convalescent cattle (Fig. 7) . This antiserum contained antibody against VIA antigen. It is seen that the immunoprecipitates contained a major peptide of approx. 56ooo daltons. Consequently, this 56ooo-dalton peptide resembles NCVP5 (or VIA antigen). Additionally, the immunoprecipitates contained peptides larger than the marker bovine serum albumin and a small but distinct peptide co-migrating with VP3. Although the peptides larger than the marker have not been identified, they appear to contain precursor(s) of VIA antigen. The peptide co-migrating with VP3 indicates a minimal cross-type specificity between VP3s of types A and C FMDV. Because constituents in the 56ooo-dalton product are precipitated by anti-VP3 serum and by antiserum containing antibody to VIA antigen, the 56ooo-dalton in vitro product is now considered to be a mixture of NCVP 5 (or VIA antigen) and a VPa precursor. The latter is presumed to be a precursor equivalent to D~ (i.e. VP3+VP 0 in EMC-and Mengo-viruses (Butterworth & Rueckert, i972; Ziola & Scraba, I974) .
DISCUSSION
The data presented in this communication show that an S-3o extract from Ehrlich ascites tumour cells effectively translated FMDV RNA for I h, producing a sixfold to ninefold stimulation of total protein synthesis over background. This long period of synthesis and the ATA inhibition of FMDV RNA-directed methionine incorporation (Table ~) both support the conclusion that chain initiation occurs in this in vitro system. However, the concentration of ATA that inhibited methionine incorporation inhibited leucine incorporation to a lesser degree, indicating that the drug permits peptide chain elongation. The results also show that FMDV RNA-directed protein synthesis in the ascites cell-free system does not require ribosome-associated initiation factors from virus-infected cells as has been reported (Ascione & Vande Woude, ~97I) for cell-free systems from BHK cells or guinea pig liver.
Results of the gel electrophoresis experiments (Fig. 3, 4 and 5) show that FMDV RNAdirected in vitro polypeptides were heterogeneous. However, a number of them co-migrated with the noncapsid proteins found in infected cell cytoplasm (NCVP2, NCVPa, NCVP5 and NCVPg) and with capsid proteins of the virus (VP1, VP2 and VP3). Approximately equivalent amounts of radioactivity were present in the regions of in vitro synthesized VP1, VP2 and VP3. Because NCVPs are precursors of VPs, it can be concluded that the ascites cell-free system has processed the primary gene product of FMDV RNA, presumably a large 2ooooo to 225ooo-dalton polypeptide (Vande Woude & Ascione, 1974) , into smaller peptides. In this respect, the present cell-free system differs from the one described previously (Ascione & Vande Woude, I97~) which generated predominantly IOOOOO-to I5OOoo-dalton polypeptides.
Synthesis of immunoprecipitable VP3 and of two presumed precursors, a and b, having the antigenic site(s) of VP3 is of interest (Fig. 6a, b) . Based on gel electrophoresis, it has been reported that NCVPI~ (moooo daltons) is the precursor of FMDV capsid proteins (Vande Woude & Ascione, 1974) . This finding suggests that in vitro peptide a of the present study is NCVPI~. As mentioned in Results, in vitro peptide b having a tool. wt. of approx. 56ooo is possibly a precursor to VP3 (Butterworth & Rueckert, I972; Ziola & Scraba, I974) . However, a 56ooo tool. wt. in vitro protein and its presumed precursor(s) precipitated strongly with the heterologous convalescent serum from type C infected cattle, indicating ~that the in vitro system also generates NCVP5 (or VIA antigen).
In summary, these experiments indicate that: 0) FMDV RNA appears to have directed the in vitro synthesis of peptides of NCVP and VP series; (2) some of the peptides of the VP series were electrophoretically indistinguishable from authentic virion peptides VP~, VP2 and VPa; (3) VP3 synthesized in vitro was immunologically indistinguishable from VPz of the virion; and (4) the in vitro 56ooo-dalton product could be immunoprecipitated with anti-VP3 serum and with antiserum containing antibody to VIA antigen.
